|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.620 USD | -2.12% |
|
-9.59% | -15.51% |
| 13/05 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
| 13/05 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 5.31 | 7.09 | 6.68 |
| Spread/Res. | -12.99% | -34.84% | -30.84% |
| Spread/Supp. | +5.96% | +18.16% | +18.16% |
| Support | 4.36 | 3.91 | 3.91 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BOLT Stock
- Charts Bolt Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition